INTRODUCTION
Chronic obstructive pulmonary disease (COPD), one of the leading health issues worldwide, is characterized by a progressive airflow limitation that is associated with a chronic inflammatory response in the airways. This persistent inflammatory state may induce pulmonary emphysema and small airway fibrosis (41). Whereas neutrophils and macrophages have been described as key effector cells involved in COPD pathogenesis, recent studies have emphasized on the role of other immune cells such as NK cells (40), NKT cells (11) and T lymphocytes in the pulmonary inflammation process and emphysema development. Focusing on T cells, numerous studies reported the presence of CD4 + and CD8 + T lymphocytes in both airways and parenchyma during COPD (14, 15, 30) and the relationship between increase in these cell populations and a greater disease severity (7, 8, 18 ). Increase of T helper (Th)-1 (17, 24), Th-2 (3, 31) or Th-17 (8, 36) cytokine expression was described in peripheral blood,
broncho-alveolar lavages (BAL) or intraepithelial COPD-associated T cells. It is now
accepted that emphysema is partly driven by pathogenic T cells inducing inflammatory damages, but the critical role of CD4 + Th cells versus CD8 + T cytotoxic (Tc) cells in emphysema remains controversial and their orientation in COPD is still unclear.
In COPD patients, a massive proteases production by lung-infiltrating inflammatory cells was described (26), supporting the protease/antiprotease imbalance theory during the pathology (27). Some of these proteases promote degradation of pulmonary elastin (23).
Accordingly, an increased secretion of desmosine, a specific marker for elastin degradation (13), and elevated levels of soluble elastin peptides (EP) in various biological fluids of COPD patients reflect massive pulmonary elastin breakdown (9, 32). In emphysematous animal models, circulating EP are associated with the lysis of nearly 60% of pulmonary elastic fibers (13). EP produced in significant amounts during proteolytic degradation of lung share miscellaneous biological activities, predominantly chemotactic activities (35) and protease release (9) that are directly involved in propagation and maintenance of inflammation associated with emphysema.
EP exhibit a wide range of biological activities (9, 12, 35) that can be attributed in their whole to the VGVAPG hexa-peptide, a peptide sequence repeated several times in the elastin monomer and the major ligand for the high affinity binding site of a receptor complex that includes a 67-kDa elastin-binding protein which is an enzymatically inactive spliced variant of -galactosidase called Spliced-galactosidase (S-gal) (16). In immune cells, we previously demonstrated that EP/S-gal interactions modulate expression of pro-inflammatory cytokines in monocytes (1) and promote a pro-inflammatory Th-1 response in stimulated human peripheral blood lymphocytes (5) . Moreover, the immunogenicity of EP was investigated during COPD and anti-elastin B-cell response was reported (22). The emergence of autoreactive T cell clones was also described during emphysema (44) and recently reported in COPD patients (4) . Interestingly, we defined in our last works a correlation between EP/S-gal interactions and alteration of neutrophil functions in COPD patients (9) or induction of emphysema-like phenotype in EP-treated mice (34).
Since EP/S-gal interactions regulate T cell response and promote development of emphysema process, we here hypothesized that such an interaction may be also involved in the emphysema-associated CD4 + and CD8 + T cell response. In this study, we demonstrated that in mice Th-1, Th-17 and Tc-1 pro-inflammatory responses observed during EP-induced emphysema could be modulated using S-gal-specific antagonist peptides.
MATERIALS AND METHODS
Animal procedure. Six-week old C57BL/6J female mice purchased from Harlan Sprague Dawley (Harlan Laboratories, Gannat, France) were housed in an animal facility that was maintained at 22-26°C with 40-69% humidity and a 12-h light/dark cycle. Animals were fed with a commercial diet and received water ad libitum. Animals were humanely cared for, and all animal experiments were approved by the University of Reims Champagne-Ardenne
Institutional Animal Care and Use Committee and were carried out in accordance with institutional guidelines and regulations. After appropriate sedation, mouse lungs were endotracheally instilled with either PBS, or one unit (7.4 µg) porcine pancreatic elastase (PPE) (Sigma-Aldrich, Saint-Quentin Fallavier, France), or 10 µg VGVAPG (Genepep SA, Saint Jean de Védas, France), or 10 µg PGAIP (Genepep SA) via a 22-gauge i.v. catheter in a total volume of 50 µl PBS as previously described (34). In some experiments, we co-thymic, cardiovascular remnants and main bronchi and trachea. Lungs from appropriate mice were also inflated, removed and embedded in paraffin to allow morphological and elastin/collagen network analysis.
Synthesis, purification and characterization of EP. Synthesis of the elastin peptides used in this study (VGVAPG and PGAIPG) was performed by Genepep (Genepep SA, Saint Jean de Védas, France). Crude peptides were purified by RP-HPLC on a semi-preparative C18-bonded silica column using a Shimadzu SPD 10A UV/VIS detector, with detection at 210 and 254 nm. The column was perfused at a flow rate of 3 ml/min with solvent A (10%, v/v, water in 0.1% aqueous TFA), and a linear gradient from 10 to 90% of solvent B (80%, v/v, acetonitrile in 0.1% aqueous TFA) over 40 min was adopted for peptide elution. Analytical purity and retention time of each peptide were determined using HPLC conditions in the above solvent system (solvents A and B). All analogous peptides showed >98% purity when monitored at 215 nm. Homogeneous fractions, as established using analytical HPLC, were pooled and lyophilized. Peptides molecular weights were determined by ESI mass spectrometry. ESI-MS analysis was made in positive ion mode. The sample was dissolved in a mixture of water and methanol (50/50) and injected directly into the electrospray source, using a syringe pump, which maintains constant flow at 5 μl/min. The temperature of the capillary was set at 220 °C. All peptides used in this study were solubilized or diluted in PBS.
Broncho-alveolar lavage. The trachea was inserted with a 22-gauge i.v. catheter, and the whole lungs were washed three times with 1 ml PBS. BALF was centrifuged at 300 x g for 10 min at +4°C, and the supernatant was collected and stored at -80°C until required. Cell pellet was resuspended in 1 ml of PBS, and cell count was performed. resuspended in fresh digestion medium, passed through a successive 70-μm and 40-µm cell strainers and centrifuged. Red blood cells were then lysed using RBC Lysis Solution (Miltenyi Biotec) and washed with X-VIVO 15 serum free medium (Lonza, Verviers, Belgium). mLN were passed through a 70-μm cell strainer, using a 1 mL syringe plunger, and washed in X-VIVO 15 serum free medium (Lonza). Spleens were also passed through a successive 70-μm and 40-µm cell strainers, using a 5 mL syringe plunger and washed twice.
The CD45 + leucocytes were isolated from lung single-cell suspensions by immuno-magnetic positive selection using mouse anti-CD45 microbeads according to the manufacturer's instructions (Miltenyi Biotec). Cell purity and viability were respectively over 98% and 90%
as determined by flow cytometry analysis. Flow cytometry analysis. Analysis of the surface antigens, intracellular cytokine and intranuclear transcription factor expressed on stimulated CD45 + leucocytes or sorted lymphocytes isolated from BALF, lung, mLN or spleen were performed using antibodies listed in Table 1 and at a target concentration determined from dose/effect specific curves. Statistical analysis. Data are presented as means±SEM. Difference among groups was analyzed using one-way ANOVA followed by the Bonferroni post hoc test. For all analyses, a p value < 0.05 was considered statistically significant. All statistical analyses were performed using GraphPad Prism (GraphPad software San Diego, CA, USA). and 3B). In contrast, exposure to VGVAPG did not impact the expression of neither IL-17a
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and IL-4 intracellular cytokines nor RORγt and GATA3 transcription factors in these cells ( Fig. 3A and 3B ). Similar results were obtained after endotracheal administration of PPE ( Fig.   2 and Fig. 3 ). Consistent with both intracellular and intra-nuclear analysis of activated splenic T cells, CBA assay showed an important IFN-γ and, to a lesser extent, IL-17a cytokine production by stimulated CD4 + splenic T cells isolated from VGVAPG-or PPE-treated groups, whereas no difference was observed in CD4 + T cell-derived IL-4 production whatever the group analysed (Fig. 4A ). Likewise, a massive production of IFN-γ was detected after anti-CD3/CD28 stimulation of splenic CD8 + T cells isolated from either VGVAPG or PPE emphysematous mice (Fig. 4B ).
Treg cell proportion is not altered in lung, mLN and spleen of VGVAPG-instilled mice.
The typical balance between Th-17 and Treg, and to a lesser extent between Th-1 and Treg (42), led us to investigate the consequences of VGVAPG endotracheal instillation of mice on the proportion of Treg (CD4 + CD25 high FoxP3 + ) cells. Compared to the control group exposed to PBS, the proportion of Treg cells remained unchanged in spleen isolated from VGVAPGtreated mice (Fig. 5A ). The lack of VGVAPG effects on the proportion of spleen Treg cells was also confirmed in lung and mLN (Fig. 5B) . Similarly, the proportion of Treg cells among the cells isolated from lung, mLN and spleen of PPE-treated mice was not modified compared to control group (Fig. 5B) .
Elastin peptides promote a Th-1/Th-17 and Tc-1 response in splenic T lymphocytes ex
vivo. We next wondered whether an ex vivo interaction between EP and S-gal expressed on the surface of Th-1, Th-17 and Tc-1 pre-oriented T lymphocytes isolated from VGVAPG- T cells (Fig. 6A ). This result was associated with a concomitant rise of activated CD4 + T-bet + and CD4 + RORγt + cells (Fig. 6B) . Similar results were obtained with CD4 + splenic T cells isolated from mice that received either PPE ( Fig. 6C and 6D ) or PBS ( Fig. 6E and 6F Tc-1 related cytokine response in VGVAPG-treated mice was linked to EP interaction with Sgal, we co-instilled mice with VGVAPG and the analogous peptide PGAIP that antagonizes the elastin peptide/elastin receptor interactions. This peptide was identified in a previous study as an inactive C-terminal glycine deleted-elastin peptide that retains its binding-activity to elastin receptor and inhibits the in vitro and in vivo activities of emphysema-inducing VGVAPG (34). We also co-instilled mice group with PPE and the antagonist peptide PGAIP to confirm our blocking strategy. In lung, mLN and spleen of mice co-treated with VGVAPG and PGAIP, the proportion of anti-CD3/CD28-activated CD4 + T cell was highly reduced compared to mice in which VGVAPG was used alone, and reached values comparable to those obtained in PBS-instilled mice and PGAIP-instilled mice (Fig. 8A, 8C and 8E). As expected, this negative shift was correlated with a significant decreased expression of the transcription factors T-bet and RORγt analyzed in the same experimental conditions (Fig. 8B,   8D and 8F). Regarding CD8 + T cell in lung, mLN and spleen, as a consequence of PGAIP efficiency, expression of IFN-γ and T-bet transcription factor was also significantly lowered in PGAIP/VGVAPG co-treated mice as revealed by values equivalent to those of PBS-treated mice and PGAIP-instilled mice (Fig. 9) . The same blocking effect of PGAIP was observed in PPE/PGAIP co-instilled mice on CD4 + and CD8 + T cells cytokines and transcription factors expression ( Fig. 8 and Fig. 9 ). T helper response is known to be regulated by appropriated Treg counterbalance effects (42). In COPD, this condition remains to be clearly elucidated. In our experimental conditions, we found that Treg cell proportion is unchanged in VGVAPG-or PPE-treated mice compared to control mice. Similar results were obtained in an acute murine model of CS-induced emphysema (10), whereas a chronic CS-exposure of mice induces an increase in pulmonary Treg number (6) . Such discrepancy is also noticed in COPD patients' studies (2, 22, 29, 38). These contradictory results could be easily explained by the differences in their experimental designs. A complete multicolor-phenotypic and functional exploration of Treg in COPD patients may resolve this controversy.
DISCUSSION
We have previously established a correlation between a type-1 profile and S-gal expression on EP treated human lymphocytes (5) . In addition, we recently demonstrated in mice that VGVAPG-induced emphysema was associated with elastin breakdown, and that deleterious effects of soluble EP on lungs could be antagonized by analogous elastin peptides (34).
Moreover, EP specific monoclonal antibodies treatment was previously described, by others, to suppress macrophages accumulation and airspace pathology development in PPE-recipient mice (19). In the present study, we demonstrated that EP-and PPE-instilled mice display a Th-1/Th-17 and Tc-1 cytokine expression pattern in lung, mLN and spleen. We therefore postulated that EP exert a central role in the development of a Th/Tc response during emphysema in mice whatever the etiologic inducer used.
In support to this hypothesis, the present study showed that the proportion of splenic T cells expressing type-1 or type-17 cytokines following VGVAPG or PPE instillation in mice was maximized after an ex vivo activation either by an elastin peptide mixture or the VGVAPG peptide. Given that this increase was also seen from the spleen of mice instilled with PBS, we can conclude that the results obtained from the spleens of VGVAPG-or PPEinstilled mice are not the consequence of the expansion of EP-specific T cell clones generated following instillation but the consequence of EP/S-gal interaction independently of any EP presentation to the TCR. In line with these results, we previously demonstrated in human peripheral blood lymphocytes that S-gal occupancy by EP leads to the activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and activation protein-1 (AP-1)
DNAbinding, key actors in the coordination of IFN-γ transcription (5).
Based on the postulate of a correlation between type-1/ type-17 cytokine production and EP/S-gal interactions on T cells, we envisaged using an elastin receptor antagonist to prove the involvement of S-gal in pulmonary T lymphocytes response. In a previous report, we described that the PGAIP peptide antagonizes the VGVAPG/S-gal interactions and abolish in mice not only the EP-dependent pulmonary emphysema but also The PPE-induced emphysema (34). We demonstrated that the PGAIP peptide protects mice from the VGVAPG-and the PPE-dependent inflammatory cell infiltration in pulmonary tissue, MMP and desmosine accumulation in BALF, and parenchymal degradation. In this study, the S-galspecific antagonist PGAIP peptide injected into murine lungs simultaneously with the VGVAPG peptide or PPE succeeded to impair the activity of etiologic inductor on Th-1/Th-17 and Tc-1 response. This result confirms the implication of S-gal receptor in T lymphocyte response during emphysema both when EP were directly administered or when they were induced par PPE biological effects. This regulation is also consistent with previously reported effects of PGAIP peptide on the protection of mice from the EP-or PPE-induced emphysema (34).
Integrated in the pathophysiological mechanisms of COPD, our results highlight an additional EP deleterious role in the generation and maintenance of the persistent inflammation observed in COPD patients. These results demonstrate that EP, whose genesis is perpetuated by induction of a self-amplification loop of inflammatory cells recruitment and proteases production, orchestrate an emphysema-associated inflammatory process through the combined production of IFN-γ and IL-17, two cytokines linked to lung destruction (37) (Fig.   10 ). Via the production of IFN-, EP favour emphysema development, dysregulation of the pulmonary proteases/anti-proteases balance (43) and major the Th-1 pro-inflammatory response (33). Through the production of both IFN- and IL-17, EP enhance the recruitment of neutrophils into the airways (28).
Taken as a whole, our data confirm the critical role of Th-1, Th-17 and Tc-1 cells in the development of emphysema and highlight the effects of the EP/S-gal interactions on T cell orientation towards a pro-inflammatory profile. Our findings also provide evidence that this orientation might be controlled by S-gal specific antagonist peptides making them potential complementary therapeutic support to prevent the progression of the inflammatory process during emphysema. Studies are in progress, to investigate the potentiality of PGAIP to control a pre-existing inflammation induced by various emphysema inducers. 
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